Real ChatGPT answer · index seedw5hKca3xucQcompleteHealth and wellness · women's healthinformational
What are the primary cardiovascular and breast cancer risks associated with starting hormone replacement therapy in your late forties based on the most recent medical studies.
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the primary cardiovascular and breast cancer risks associated with starting hormone replacement therapy in your late forties based on the most recent medical studies.
7 real searches · 1 real-search pass
2025 2026 menopausal hormone therapy cardiovascular risk breast cancer evidence guideline age under 60 within 10 years menopause randomized trials reviewGoogle ↗
OBSERVEDReason
North American Menopause Society hormone therapy position statement cardiovascular breast cancer risk age younger than 60 within 10 years menopause transdermalGoogle ↗
OBSERVEDConsequence
2024 2025 menopause hormone therapy breast cancer risk estrogen progesterone type duration study cardiovascular venous thromboembolism strokeGoogle ↗
OBSERVEDReason
latest 2026 menopause hormone therapy cardiovascular breast cancer risks evidence studies guidelineGoogle ↗
OBSERVEDComparison
2024 2025 menopause hormone therapy cardiovascular risk breast cancer age under 60 timing route transdermal evidence review guidelineGoogle ↗
OBSERVEDReason
North American Menopause Society hormone therapy cardiovascular breast cancer risk age younger than 60 10 years menopause position statementGoogle ↗
OBSERVEDDefinition
2024 systematic review menopausal hormone therapy breast cancer risk estrogen progesterone micronized progesterone transdermalGoogle ↗
OBSERVEDComparison
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (7)
Classes come from the query-classifier (a local Laya model). 7 of 7 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT7 real searches · gpt-6
2025 2026 menopausal hormone therapy cardiovascular risk breast cancer evidence guideline age under 60 within 10 years menopause randomized trials review Google ↗
North American Menopause Society hormone therapy position statement cardiovascular breast cancer risk age younger than 60 within 10 years menopause transdermal Google ↗
2024 2025 menopause hormone therapy breast cancer risk estrogen progesterone type duration study cardiovascular venous thromboembolism stroke Google ↗
latest 2026 menopause hormone therapy cardiovascular breast cancer risks evidence studies guideline Google ↗
2024 2025 menopause hormone therapy cardiovascular risk breast cancer age under 60 timing route transdermal evidence review guideline Google ↗
North American Menopause Society hormone therapy cardiovascular breast cancer risk age younger than 60 10 years menopause position statement Google ↗
2024 systematic review menopausal hormone therapy breast cancer risk estrogen progesterone micronized progesterone transdermal Google ↗
- Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway · nature.com
- In perimenopausal and postmenopausal women, what are the long-term effects of using hormone therapy for at least one year? · cochrane.org
- Contemporary menopausal hormone therapy and thrombotic disease: nationwide nested case-control study. · pubmed.ncbi.nlm.nih.gov
- Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper. · pubmed.ncbi.nlm.nih.gov
- Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper · pmc.ncbi.nlm.nih.gov
- Hormone therapy safety · womenshealth.gov
- Updated Labeling for Menopausal Hormone Therapy | Women's Health | JAMA · doi.org
Semantic map
Every query placed by meaning (EmbeddingGemma 2, 256-d). Shaded regions are topics, nearby points are near-paraphrases, and a circle's size is how often the query came back.
Colour
SimulatedReal search
Hover a query to see its counterpart · zoom with Ctrl/⌘ + scroll, a pinch, double-click or +
Queries
7 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2025 2026 menopausal hormone therapy cardiovascular risk breast cancer evidence guideline age under 60 within 10 years menopause randomized trials review OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
North American Menopause Society hormone therapy position statement cardiovascular breast cancer risk age younger than 60 within 10 years menopause transdermal OBSERVED | Google ↗ AI Mode ↗ | — | Consequence | — | — | 1x of 1 | |
2024 2025 menopause hormone therapy breast cancer risk estrogen progesterone type duration study cardiovascular venous thromboembolism stroke OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
latest 2026 menopause hormone therapy cardiovascular breast cancer risks evidence studies guideline OBSERVED | Google ↗ AI Mode ↗ | — | Comparison | — | — | 1x of 1 | |
2024 2025 menopause hormone therapy cardiovascular risk breast cancer age under 60 timing route transdermal evidence review guideline OBSERVED | Google ↗ AI Mode ↗ | — | Reason | — | — | 1x of 1 | |
North American Menopause Society hormone therapy cardiovascular breast cancer risk age younger than 60 10 years menopause position statement OBSERVED | Google ↗ AI Mode ↗ | — | Definition | — | — | 1x of 1 | |
2024 systematic review menopausal hormone therapy breast cancer risk estrogen progesterone micronized progesterone transdermal OBSERVED | Google ↗ AI Mode ↗ | — | Comparison | — | — | 1x of 1 |